Manchester Capital Management LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1393389 MANCHESTER, VT

Position in REGN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$35,541

+$2,351 QoQ

Shares Held

+7.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Manchester Capital Management LLC holds $538,294 across 24 Biotechnology names. REGN ranks #3 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396	$176,829
2	INSM	INSMED Inc	1,017	$166,299
3	REGN	Regeneron Pharmaceuticals, Inc. This page	46	$35,541
4	ALNY	Alnylam Pharmaceuticals, Inc.	86	$28,454
5	RPRX	Royalty Pharma plc	587	$28,158
6	ABVX	Abivax S.A.	200	$22,270
7	CRSP	CRISPR Therapeutics AG	400	$19,028
8	MRNA	Moderna, Inc.	372	$18,897

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,541	46	+7.0%	Shares	Sole	2026-05-11
2025-12-31	$33,190	43	-84.0%	Shares	Sole	2026-02-11
2025-09-30	$150,688	268	-5.6%	Shares	Sole	2025-11-14
2025-06-30	$149,100	284	+27.4%	Shares	Sole	2025-08-12
2025-03-31	$141,433	223	+38.5%	Shares	Sole	2025-05-09
2024-12-31	$114,685	161	+12.6%	Shares	Sole	2025-01-30
2024-09-30	$150,327	143	0.0%	Shares	Sole	2024-11-05
2024-06-30	$150,297	143	+93.2%	Shares	Sole	2024-08-08
2024-03-31	$71,224	74	+13.8%	Shares	Sole	2024-05-06
2023-12-31	$57,088	65	+18.2%	Shares	Sole	2024-02-08
2023-09-30	$45,262	55	0.0%	Shares	Sole	2023-11-09
2023-06-30	$39,519	55	+31.0%	Shares	Sole	2023-08-14
2023-03-31	$34,510	42	+740.0%	Shares	Sole	2023-05-09
2022-12-31	$3,607	5	+66.7%	Shares	Sole	2023-02-09
2020-12-31	$1,449	3	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.